U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H22O5
Molecular Weight 282.3322
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ARTEMISININ

SMILES

[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(OC(=O)[C@@H]2C)O4

InChI

InChIKey=BLUAFEHZUWYNDE-NNWCWBAJSA-N
InChI=1S/C15H22O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-11,13H,4-7H2,1-3H3/t8-,9-,10+,11+,13-,14-,15-/m1/s1

HIDE SMILES / InChI

Molecular Formula C15H22O5
Molecular Weight 282.3322
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:05:50 UTC 2023
Edited
by admin
on Fri Dec 15 16:05:50 UTC 2023
Record UNII
9RMU91N5K2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ARTEMISININ
INCI   INN   MART.   MI   USP-RS   WHO-DD   WHO-IP  
INN   INCI  
Official Name English
QING HAU SAU
Common Name English
GNF-PF-5341
Code English
ARTEMISININUM [WHO-IP LATIN]
Common Name English
ARTEMISININ [MART.]
Common Name English
HUANGHUAHAOSU
Common Name English
artemisinin [INN]
Common Name English
ARTEMISININ [INCI]
Common Name English
Artemisinin [WHO-DD]
Common Name English
ARTEMISININ [WHO-IP]
Common Name English
NSC-369397
Code English
ARTEMISININ [MI]
Common Name English
ARTEMISININ [USP-RS]
Common Name English
(3R,5AS,6R,8AS,9R,12S,12AR)-3,6,9-TRIMETHYLOCTAHYDRO-3,12-EPOXYPYRANO(4,3-J )-1,2-BENZODIOXEPIN-10(3H)-ONE
Systematic Name English
(3R,5AS,6R,8AS,9R,12S,12AR)-OCTAHYDRO-3,6,9-TRIMETHYL-3,12-EPOXY-12H-PYRANO(4,3-J)-1,2-BENZODIOXEPIN-10(3H)-ONE
Common Name English
Classification Tree Code System Code
DSLD 2508 (Number of products:21)
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
LIVERTOX 64
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
WHO-ATC P01BE01
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
NCI_THESAURUS C277
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
Code System Code Type Description
NSC
369397
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
DAILYMED
9RMU91N5K2
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
ARTEMISININ
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY Description: Colourless needles or white crystalline powder. Solubility: Practically insoluble in water; very soluble in dichloromethane R; freely soluble in acetone R and ethyl acetate R; soluble in glacial acetic acid R, methanol R and ethanol (~750 g/L) TS. Category: Antimalarial. Storage: Artemisinin should be kept in a well-closed container and protected from light. Requirement: Artemisinin contains not less than 97.0% and not more than 102.0% of C15H22O5, calculated with reference to the dried substance.
EPA CompTox
DTXSID2040652
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
DRUG CENTRAL
3871
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
RXCUI
2367409
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
DRUG BANK
DB13132
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
NCI_THESAURUS
C78093
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
MESH
C031327
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
INN
5954
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
WIKIPEDIA
ARTEMISININ
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
CAS
63968-64-9
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
MERCK INDEX
m2077
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY Merck Index
FDA UNII
9RMU91N5K2
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
PUBCHEM
68827
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
SMS_ID
100000086624
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
CHEBI
223316
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
EVMPD
SUB05575MIG
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL567597
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
RS_ITEM_NUM
1042747
Created by admin on Fri Dec 15 16:05:50 UTC 2023 , Edited by admin on Fri Dec 15 16:05:50 UTC 2023
PRIMARY
Related Record Type Details
DERIVATIVE -> PARENT
Related Record Type Details
METABOLITE ACTIVE -> PRODRUG
Related Record Type Details
PARENT -> IMPURITY
PARENT -> IMPURITY
In the chromatogram obtained with solution (1): the area of any peak corresponding to impurity B (artemisinin) is not greater than 0.5 times the area of the principal peak obtained with solution (4) (0.5%).
CHROMATOGRAPHIC PURITY (HPLC/UV)
IMPURITY -> PARENT
IMPURITY -> PARENT
Related Record Type Details
ACTIVE MOIETY